Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

BloodStemPLUS

Financiado

Cerrado

Commercial feasibility study of a technology that multiplies blood stem cells to...

Commercial feasibility study of a technology that multiplies blood stem cells to increase the success of transplants for cancer treatment StemCell2MAX is a biotechnology start-up that owns a proprietary solution for multiplying blood stem cells. Blood stem cells are required for both research and blood cancer treatment, but are scarce resulting in limited transplant... ver más

30/09/2016

StemCell2MAX

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

GROWINGFORMULA LDA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2016-09-30

SMEInst-05-2016-2017: Supporting innovative SMEs in the h...

I+D

Cerrada hace 8 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

StemCell2MAX

50.00K€ | Lider

Proyectos interesantes

NOVEXPAND

Medical Technol...

Biotechnology

181K€ Cerrado

HYPERLAB

Medical Technol...

Biotechnology

4M€ Cerrado

DESARROLLO DE NUEVAS TERAPIAS CELULARES BASAD...

Medical Technol...

Biotechnology

443K€ Cerrado

STEMEXPAND

Medical Technol...

Biotechnology

4M€ Cerrado

EBISC

Medical Technol...

Biotechnology

34M€ Cerrado

PROMETHEUS

Medical Technol...

Biotechnology

3M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 4 meses Fecha Inicio: 2016-05-21
Fecha Fin: 2016-09-30

Líder del proyecto

GROWINGFORMULA LDA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto StemCell2MAX is a biotechnology start-up that owns a proprietary solution for multiplying blood stem cells. Blood stem cells are required for both research and blood cancer treatment, but are scarce resulting in limited transplants (34% of patients do not find a donor), patient death (6-15%) and limitations at research level (12.500 groups lack cells for their studies). StemCell2MAX addresses this enormous demand from patients, cord blood banks, hospitals and researchers in an estimated €3 billion potential market (33% CAGR). No solution for blood stem cell multiplication is available for clinical purposes and those that are currently used for research purposes compromise cell quality. StemCell2MAX has developed a product that multiplies these cells while assuring their quality (20x better results compared to state of the art, as published in Nature). Currently, StemCell2MAX markets a research use only product (€600M market) with a growing sales track record, both in EU and USA. Following the technology’s market acceptance and scientific recognition, StemCell2MAX is preparing their solution for the €2.4B clinical market. The innovation is protected in EU, USA and Japan for blood stem cell maintenance, expansion or transplantation, for both research and clinical use. StemCell2MAX won the most investable company award during the first Horizon 2020 – Invest Horizon Global Investor Summit in November 2015. Specific objectives: • To develop a business plan and marketing strategy for clinical application • To explore strategic partnerships for development and commercialisation • To explore the clinical validation strategy/clinical trial design • To develop a strategic development plan in agreement with reimbursement policies Expected outcomes: • A business plan and optimal route-to-market, including partnering strategy for further development • Clinical trial strategy in compliance with all regulatory requirements

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores